Select your timezone:

Oral Abstract Session
Islet Transplantation: Addressing innate inflammation

Friday October 27, 2023 | 05:30 to 06:25
Room: Indigo A
Track: N/A

Presentations

Haval Shirwan, United States
Co-engineering pancreatic islets with novel forms of thrombomodulin and CD47 as an effective means of mitigating instant blood-mediated inflammatory reaction

Dr. Tasneem R Abdel-Karim, United States
No differences in long-term diabetes outcomes with etanercept or alpha-1 antitrypsin treatment in total pancreatectomy and islet autotransplantation: A randomized controlled pilot study

Miss ChaeRim Yoo, Korea
Neutralization of HMGB1 released from pancreatic islet via surface camouflage having glycol chitosan-glycyrrhizin conjugate

Dr. Mazhar A Kanak, United States
Islet stressomes released during isolation and in response to inflammation may affect outcomes in islet auto-transplantation

Ms. Cyril P Landstra, Netherlands
TNF-alpha blockade during islet transplantation in immunosuppressed recipients: a study on in vitro, clinical, and CITR registry-derived data

Organized by

Supported by

Hosted by


IPITA-IXA-CTRMS Joint Congress • San Diego, CA, USA • October 26-29, 2023
© 2024 IPITA-IXA-CTRMS 2023